Melatonin and docosahexaenoic acid decrease proliferation of PNT1A prostate benign cells via modulation of mitochondrial bioenergetics and ROS production

Melatonin and docosahexaenoic acid decrease proliferation of PNT1A prostate benign cells via modulation of mitochondrial bioenergetics and ROS production

Guilherme H. Tamarindo, Daniele L. Ribeiro, Marina G. Gobbo, Luiz H. A. Guerra, Paula Rahal, Sebastiao R. Taboga, Fernanda R. Gadelha, Rejane M. Goes

ARTIGO

Inglês

Prostate cancer development has been associated with changes in mitochondria' activity and reactive oxygen species (ROS) production. Melatonin (MLT) and docosahexaenoic acid (DHA) have properties to modulate both, but their protective role, mainly at early stages of prostate cancer, remains unclear....

CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ

FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP

COORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPES

Aberto

Melatonin and docosahexaenoic acid decrease proliferation of PNT1A prostate benign cells via modulation of mitochondrial bioenergetics and ROS production

Guilherme H. Tamarindo, Daniele L. Ribeiro, Marina G. Gobbo, Luiz H. A. Guerra, Paula Rahal, Sebastiao R. Taboga, Fernanda R. Gadelha, Rejane M. Goes


										

Melatonin and docosahexaenoic acid decrease proliferation of PNT1A prostate benign cells via modulation of mitochondrial bioenergetics and ROS production

Guilherme H. Tamarindo, Daniele L. Ribeiro, Marina G. Gobbo, Luiz H. A. Guerra, Paula Rahal, Sebastiao R. Taboga, Fernanda R. Gadelha, Rejane M. Goes

    Fontes

    Oxidative medicine and cellular longevity

    Vol. 219 (Jan., 2019), n. art. 5080798